Teladoc Health
TDOC
889 hedge funds and large institutions have $22.1B invested in Teladoc Health in 2021 Q1 according to their latest regulatory filings, with 130 funds opening new positions, 349 increasing their positions, 298 reducing their positions, and 130 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 349 | Existing positions reduced: 298
0% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 130
1% less funds holding
Funds holding: 900 → 889 (-11)
1.32% less ownership
Funds ownership: 81.02% → 79.7% (-1.3%)
7% less capital invested
Capital invested by funds: $23.7B → $22.1B (-$1.56B)
29% less funds holding in top 10
Funds holding in top 10: 24 → 17 (-7)
46% less call options, than puts
Call options by funds: $1.31B | Put options by funds: $2.42B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.53B |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$376M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$362M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$340M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$162M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$966M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$349M |
| 3 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
-$311M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$301M |
| 5 |
BlackRock
New York
|
-$114M |
TDOC Hedge Fund Activity: Q1 2021 in Review
889 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q1 2021, worth a combined $22.1B — down 6.6% from $23.7B a quarter earlier.
Fund positioning in TDOC was balanced in Q1 2021: 130 funds opened new positions, 130 closed out, 349 added to existing stakes and 298 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $1.53B. The largest seller was Jennison Associates, cutting an estimated $966M.
- 889 institutional investors held Teladoc Health (TDOC) as of Q1 2021, down from 900 in Q4 2020.
- Funds reported $22.1B of Teladoc Health stock for Q1 2021, down 6.6% quarter-over-quarter.
- 130 funds opened new Teladoc Health positions in Q1 2021 and 130 closed out, a net change of 0 holders.
- The largest Teladoc Health buyer in Q1 2021 was ARK Investment Management, an estimated $1.53B added.
- The largest Teladoc Health seller in Q1 2021 was Jennison Associates, an estimated $966M sold.
Based on aggregated 13F filings for Q1 2021.